Submitted by Anonymous (not verified) on 14 July 2025 - 17:08
Human medicines European public assessment report (EPAR): Vabysmo, faricimab, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vabysmo, faricimab, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised